Connection

Cynthia Timmers to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Cynthia Timmers has written about Drug Resistance, Neoplasm.
Cynthia Timmers
Connection Strength
0.416
Drug Resistance, Neoplasm
  1. KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer. J Natl Compr Canc Netw. 2019 05 01; 17(5):409-413.
    View in: PubMed
    Score: 0.134
  2. Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma. Oncologist. 2019 07; 24(7):989-996.
    View in: PubMed
    Score: 0.134
  3. A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma. Cancer Res. 2017 01 01; 77(1):153-163.
    View in: PubMed
    Score: 0.113
  4. Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Cold Spring Harb Mol Case Stud. 2019 08; 5(4).
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.